Lonza Group Ltd (LZAGF)
537.04
-22.96
(-4.10%)
USD |
OTCM |
May 01, 16:00
Lonza Group Market Cap: 38.73B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 38.73B |
| April 30, 2024 | 40.39B |
| April 29, 2024 | 41.47B |
| April 26, 2024 | 39.93B |
| April 25, 2024 | 39.38B |
| April 24, 2024 | 40.22B |
| April 23, 2024 | 40.30B |
| April 22, 2024 | 39.03B |
| April 19, 2024 | 39.52B |
| April 18, 2024 | 40.64B |
| April 17, 2024 | 41.76B |
| April 16, 2024 | 41.29B |
| April 15, 2024 | 41.66B |
| April 12, 2024 | 42.34B |
| April 11, 2024 | 42.57B |
| April 10, 2024 | 41.93B |
| April 09, 2024 | 43.51B |
| April 08, 2024 | 43.45B |
| April 05, 2024 | 43.49B |
| April 04, 2024 | 43.71B |
| April 03, 2024 | 44.24B |
| April 02, 2024 | 42.22B |
| April 01, 2024 | 43.27B |
| March 28, 2024 | 43.38B |
| March 27, 2024 | 43.05B |
| Date | Value |
|---|---|
| March 26, 2024 | 42.69B |
| March 25, 2024 | 42.24B |
| March 22, 2024 | 42.12B |
| March 21, 2024 | 42.47B |
| March 20, 2024 | 42.84B |
| March 19, 2024 | 39.20B |
| March 18, 2024 | 39.09B |
| March 15, 2024 | 39.81B |
| March 14, 2024 | 39.18B |
| March 13, 2024 | 38.90B |
| March 12, 2024 | 37.36B |
| March 11, 2024 | 37.89B |
| March 08, 2024 | 38.14B |
| March 07, 2024 | 38.51B |
| March 06, 2024 | 37.36B |
| March 05, 2024 | 37.21B |
| March 04, 2024 | 37.43B |
| March 01, 2024 | 38.26B |
| February 29, 2024 | 37.57B |
| February 28, 2024 | 38.22B |
| February 27, 2024 | 38.22B |
| February 26, 2024 | 37.45B |
| February 23, 2024 | 38.40B |
| February 22, 2024 | 38.01B |
| February 21, 2024 | 37.14B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
22.60B
Minimum
May 07 2019
63.31B
Maximum
Sep 02 2021
41.00B
Average
42.29B
Median
Mar 09 2023
Market Cap Benchmarks
| Roche Holding AG | 189.74B |
| AC Immune SA | 247.25M |
| CRISPR Therapeutics AG | 4.619B |
| Addex Therapeutics Ltd | 8.689M |
Market Cap Related Metrics
| PE Ratio | 54.07 |
| PS Ratio | 5.255 |
| Price to Book Value | 3.442 |
| Price | 537.04 |
| Earnings Yield | 1.85% |
| Operating PE Ratio | 40.57 |
| Normalized PE Ratio | 53.86 |